AJR Am J Roentgenol
- THOMAS M
Editorial Comment: Abbreviated Breast MRI on Repeat-Is This a New Era for Breast
Cancer Screening?
AJR Am J Roentgenol. 2024 Jun 5. doi: 10.2214/AJR.24.31513.
Am J Surg
- PESAVENTO CM, Kazemi RJ, Kappelman A, Thompson JL, et al
Pilot testing a patient decision aid as a strategy to reduce overtreatment for
older women with early-stage breast cancer.
Am J Surg. 2024 May 25:115774. doi: 10.1016/j.amjsurg.2024.115774.
Ann Oncol
- ORLANDI A, Mastrantoni L, Bria E, Tortora G, et al
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean
survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal
aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer:
Final overall
Ann Oncol. 2024 Jun 3:S0923-7534(24)00719-1. doi: 10.1016/j.annonc.2024.
- SHERRY AD, Lin TA, McCaw ZR, Ludmir EB, et al
Interpretation of long-term survival data from MONARCH 3. Letter to the Editor
regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy
for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH
3' by M.
Ann Oncol. 2024 Jun 3:S0923-7534(24)00718-X. doi: 10.1016/j.annonc.2024.
Ann Surg Oncol
- BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related
Lymphedema in Underserved Ethnically Diverse Population.
Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15577.
- JUNG JJ, Cheun JH, Kang E, Shin I, et al
ASO Visual Abstract: Survival After the Contralateral Axillary Metastasis in
Breast Cancer.
Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15546.
- GILMORE RC, Fine RE
Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage
Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in
the ICE3 Trial.
Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15502.
- MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical
Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491.
- KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in
Legacy Alliance Trials (AFT-01).
Ann Surg Oncol. 2024 Jun 2. doi: 10.1245/s10434-024-15477.
Anticancer Res
- OMORI S, Ijichi H, Wakasugi A, Shigechi T, et al
Association Between Preoperative Osteopenia and Prognosis in Breast Cancer
Patients.
Anticancer Res. 2024;44:2671-2679.
- RADES D, Janssen S, Narvaez-Wolf CA, Kristiansen C, et al
Seasonal Impact on Grade >/=2 Dermatitis in Patients With Breast Cancer Undergoing
Radiotherapy: A Supplementary Analysis.
Anticancer Res. 2024;44:2617-2620.
- SUWANNALERT P, Panpinyaporn P, Wantanachaisaeng P, Teeppaibul T, et al
A Potential Combination of Targeting HSP90 and mTOR in Breast Cancer Cell Growth,
Migration, and Invasion Through Inhibiting AKT Phosphorylation and F-actin
Organization.
Anticancer Res. 2024;44:2555-2565.
- SUGAWARA-KOMATSU K, Fujii T, Kurozumi S, Ishikawa H, et al
Significance of MUC1 and beta-Catenin Localization in Mucinous Carcinoma of the
Breast.
Anticancer Res. 2024;44:2689-2698.
- MOKBEL K, Mokbel K
Harnessing Micronutrient Power: Vitamins, Antioxidants and Probiotics in Breast
Cancer Prevention.
Anticancer Res. 2024;44:2287-2295.
- GUNNELLINI M, Tornincasa A, Montedoro M, Caprodossi A, et al
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a
Therapeutic Success.
Anticancer Res. 2024;44:2755-2758.
- PIOQUINTO-AVILA E, Gonzalez-Cruz AO, Solis-Estrada J, Hernandez-Juarez J, et al
Anticancer Activity of HER2-targeting CPP-PTEN-THP Chimeric Proteins.
Anticancer Res. 2024;44:2567-2575.
- CHANG CM, Pekkle Lam HY
Intratumoral Microbiota: Unraveling their Oncogenic Impact on Cancer Progression
With Focus on Breast Cancer Therapeutic Outcomes.
Anticancer Res. 2024;44:2271-2285.
- WOO SH, Jung BC, Kim JY, Lee YH, et al
Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death
of MCF-7 Breast Cancer Cells.
Anticancer Res. 2024;44:2407-2415.
- CHU J, DO SI, Kim HS
Age-related Differences in Spatially Resolved Transcriptomic Profiles of Patients
With Hormone Receptor-positive Breast Carcinoma.
Anticancer Res. 2024;44:2605-2616.
- AGHIMIEN MO, Kolawole Q, Igbinoba PO, Musa MA, et al
Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine
Oxidase (HMAO) Enzymes.
Anticancer Res. 2024;44:2335-2341.
BMC Cancer
- XU JX, Zhu QL, Bi YM, Peng YC, et al
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a
drug-target mendelian randomization analysis.
BMC Cancer. 2024;24:691.
- YE J, Ying J, Chen H, Wu Z, et al
PPIH acts as a potential predictive biomarker for patients with common solid
tumors.
BMC Cancer. 2024;24:681.
Br J Cancer
- RYU H, Shin KH, Chang JH, Jang BS, et al
A nationwide study of breast reconstruction after mastectomy in patients with
breast cancer receiving postmastectomy radiotherapy: comparison of complications
according to radiotherapy fractionation and reconstruction procedures.
Br J Cancer. 2024 Jun 5. doi: 10.1038/s41416-024-02741.
Breast Cancer
- CHEN Y, Zhou Y, Chen J, Yang J, et al
Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression.
Breast Cancer. 2024 Jun 4. doi: 10.1007/s12282-024-01574.
Breast Cancer (Auckl)
- YU M, Liu Y, Huang Z, Zhu Q, et al
The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant
Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A
Meta-analysis.
Breast Cancer (Auckl). 2024;18:11782234241255856.
Breast Cancer (Dove Med Press)
- FENTAW S, Godana AA, Abathun D, Chekole DM, et al
Comparative Analysis of Women's Breast Cancer Survival Time at Three Selected
Government Referral Hospitals in Ethiopia's Amhara Region Using Parametric Shared
Frailty Models.
Breast Cancer (Dove Med Press). 2024;16:269-287.
- GUO L, Hong SC, Wang X, Wang SQ, et al
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in
Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial.
Breast Cancer (Dove Med Press). 2024;16:289-303.
Breast Cancer Res
- MORLA-BARCELO PM, Laguna-Macarrilla D, Cordoba O, Matheu G, et al
Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights
into early-stage breast cancer.
Breast Cancer Res. 2024;26:89.
- BOISSIN C, Wang Y, Sharma A, Weitz P, et al
Deep learning-based risk stratification of preoperative breast biopsies using
digital whole slide images.
Breast Cancer Res. 2024;26:90.
- JOHN EM, Koo J, Phipps AI, Longacre TA, et al
Reproductive characteristics, menopausal status, race and ethnicity, and risk of
breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer
Etiology in Minorities study.
Breast Cancer Res. 2024;26:88.
- FARALDO MM, Romagnoli M, Wallon L, Dubus P, et al
Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like
breast tumors by restricting luminal progenitor cell expansion.
Breast Cancer Res. 2024;26:91.
- JIN X, Yang S, Lu X, Chen X, et al
Increased expression of REG3A promotes tumorigenic behavior in triple negative
breast cancer cells.
Breast Cancer Res. 2024;26:92.
- DUIVON M, Lequesne J, Di Meglio A, Pradon C, et al
Inflammation at diagnosis and cognitive impairment two years later in breast
cancer patients from the Canto-Cog study.
Breast Cancer Res. 2024;26:93.
- ZHANG X, An K, Ge X, Sun Y, et al
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA
stability through m(5)C methylation.
Breast Cancer Res. 2024;26:94.
Breast Cancer Res Treat
- YIN C, Li H, Zhang B, Liu Y, et al
Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and
invasion of human breast cancer cells through actin polymerization and
epithelial-mesenchymal transition.
Breast Cancer Res Treat. 2024 Jun 6. doi: 10.1007/s10549-024-07392.
- FRANCOIS C, Mailliez A, Chretien S, Leguillette C, et al
Therapeutic impact of (18)F-FDG PET/CT for initial staging in patients with
clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.
Breast Cancer Res Treat. 2024 Jun 5. doi: 10.1007/s10549-024-07386.
- SCOTT OW, TinTin S, Cavadino A, Elwood JM, et al
Beta-blocker use and breast cancer outcomes: a meta-analysis.
Breast Cancer Res Treat. 2024 Jun 5. doi: 10.1007/s10549-024-07263.
- ELSON NC, Wernke K, Yoder LM, Fellner AN, et al
Universal genetic counseling in breast cancer patients significantly improves
overall testing rates and improves completion rates in subpopulations.
Breast Cancer Res Treat. 2024 Jun 1. doi: 10.1007/s10549-024-07329.
- SHI W, Xu C, Lei P, Sun X, et al
A correlation study of adhesion G protein-coupled receptors as potential
therapeutic targets for breast cancer.
Breast Cancer Res Treat. 2024 Jun 4. doi: 10.1007/s10549-024-07373.
Cancer
- SELMOUNI F, Bendahhou K, Sauvaget C, Abahssain H, et al
Impact of CBE-based screening program on care pathway, stage at diagnosis, nature
of treatment, and overall survival among breast cancer patients in Morocco.
Cancer. 2024 Jun 4. doi: 10.1002/cncr.35419.
Cancer Cell
- MCGINNIS CS, Miao Z, Superville D, Yao W, et al
The temporal progression of lung immune remodeling during breast cancer
metastasis.
Cancer Cell. 2024 May 24:S1535-6108(24)00167-3. doi: 10.1016/j.ccell.2024.
- LAYER N, Bunse L, Venkataramani V
Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune
system.
Cancer Cell. 2024 May 17:S1535-6108(24)00170-3. doi: 10.1016/j.ccell.2024.
Cancer Epidemiol Biomarkers Prev
- YAGHJYAN L, Wang Z, Warner ET, Rosner B, et al
Reproductive Factors Related to Childbearing and a Novel Automated Mammographic
Measure, V.
Cancer Epidemiol Biomarkers Prev. 2024;33:804-811.
- LOHANI KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, et al
Understanding benign breast disease and subsequent breast cancer in Hispanic
white females; a step closer to evidence-based management.
Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0204
Cancer Res
- ELEMENTO O
How Artificial Intelligence Unravels the Complex Web of Cancer Drug Response.
Cancer Res. 2024;84:1745-1746.
- SUN X, Verma SP, Jia G, Wang X, et al
Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants that Confer
Risk for Breast Cancer.
Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-3854.
- TUCKER JB, Carlsen CL, Scribano CM, Pattaswamy SM, et al
CENP-E inhibition induces chromosomal instability and synergizes with diverse
microtubule-targeting agents in breast cancer.
Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-3332.
Clin Breast Cancer
- YANG FA, Wu PJ, Su YT, Strong PC, et al
Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Systematic
Review and Meta-Analysis of Randomized Controlled Trials.
Clin Breast Cancer. 2024 May 1:S1526-8209(24)00113.
- LI N, Xiao C, Li Y, Zhang Y, et al
Association of Chlamydia trachomatis Infection With Breast Cancer Risk and the
Modification Effect of IL-12.
Clin Breast Cancer. 2024 May 10:S1526-8209(24)00116.
- DALY GR, Dowling GP, Hamza E, AlRawashdeh M, et al
Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in
Women With Breast Cancer >/= 70 Years Old?
Clin Breast Cancer. 2024 May 7:S1526-8209(24)00115.
- LIU M, Xiang Q, Dai F, Yuan Y, et al
Comparison of the Pathological Complete Response Rate and Survival Between
HER2-Low and HER2-Zero Breast Cancer in Neoadjuvant Chemotherapy Setting: A
Systematic Review and Meta-Analysis.
Clin Breast Cancer. 2024 May 10:S1526-8209(24)00114.
Clin Cancer Res
- JANK P, Karn T, van Mackelenbergh M, Lindner J, et al
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in
breast cancer patients from four prospective clinical trials.
Clin Cancer Res. 2024 Jun 5. doi: 10.1158/1078-0432.CCR-24-0459.
- ZHANG Q, Cai Z, Gerratana L, Davis AA, et al
Early evaluation of risk stratification and clinical outcomes for patients with
advanced breast cancer through combined monitoring of baseline circulating tumor
cells and DNA.
Clin Cancer Res. 2024 Jun 3. doi: 10.1158/1078-0432.CCR-24-0535.
- MAKHLIN I, Demissei BG, D'Agostino R, Hundley WG, et al
Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in
the PREVENT Randomized Clinical Trial.
Clin Cancer Res. 2024;30:2370-2376.
Eur J Surg Oncol
- YEO HAO XUAN M, Masuda Y
Reply to: Surgery vs. non-surgery for liver metastases from primary breast
cancer.
Eur J Surg Oncol. 2024 May 29:108446. doi: 10.1016/j.ejso.2024.108446.
Histopathology
- LAOKULRATH N, Gudi M, Salahuddin SA, Chong APY, et al
Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice
points and challenges.
Histopathology. 2024 Jun 6. doi: 10.1111/his.15213.
- MILIGY IM, Awasthi R, Mir Y, Khurana A, et al
Morphological and molecular changes of oestrogen receptor-positive breast cancer
following bridging endocrine therapy: a United Kingdom multicentre study.
Histopathology. 2024 Jun 7. doi: 10.1111/his.15238.
J Clin Oncol
- SOLDATO D, Michiels S, Havas J, Di Meglio A, et al
Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast
Cancer.
J Clin Oncol. 2024 Jun 5:JCO2301959. doi: 10.1200/JCO.23.01959.
- CHAVEZ-MACGREGOR M, Miao J, Pusztai L, Goetz MP, et al
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy +/- 1 Year of
Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage
Breast Cancer.
J Clin Oncol. 2024 Jun 4:JCO2302344. doi: 10.1200/JCO.23.02344.
- BOSTANY G, Chen Y, Francisco L, Dai C, et al
Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy
and Cardiovascular Risk Factors.
J Clin Oncol. 2024 Jun 4:JCO2301779. doi: 10.1200/JCO.23.01779.
- SCHNEIDER BP, Zhao F, Ballinger TJ, Garcia SF, et al
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of
Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast
Cancer.
J Clin Oncol. 2024 Jun 3:JCO2400526. doi: 10.1200/JCO.24.00526.
- CHAPMAN JW, Bayani J, SenGupta S, Bartlett JMS, et al
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and
Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast
Cancer Trial of Exemestane Versus Anastrozole.
J Clin Oncol. 2024 Jun 2:JCO2400835. doi: 10.1200/JCO.24.00835.
J Natl Cancer Inst
- LIN J, Ouyang Y, Li Y, Jin L, et al
Different dosage forms of GnRHa with endocrine therapy in premenopausal hormone
Receptor-Positive breast cancer.
J Natl Cancer Inst. 2024 Jun 4:djae115. doi: 10.1093.
- CHUA AV JR, Sheng H, Liang E, Gandhi S, et al
Epidemiology of early vs. Late recurrence among women with Early-Stage estrogen
Receptor-Positive breast cancer in the pathways study.
J Natl Cancer Inst. 2024 Jun 6:djae128. doi: 10.1093.
J Surg Oncol
- SALGADO MRT, Sobral DV, Martins MR, Salgado EFMT, et al
Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with
triple-negative breast cancer.
J Surg Oncol. 2024 Jun 6. doi: 10.1002/jso.27725.
- SOBRAL DV, Salgado MRT, Martins MR, Vasconcelos CS, et al
Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and
CD44+/CD24(neg) cells in the locally advanced and metastatic breast cancer.
J Surg Oncol. 2024 Jun 2. doi: 10.1002/jso.27716.
- CHEN JC, Handley D, Elsaid MI, Fisher JL, et al
Racial disparities in disease-specific mortality and surgical management of
patients with ductal carcinoma in situ with microinvasion.
J Surg Oncol. 2024;129:1179-1186.
- KIM M, Vingan P, Boe LA, Tadros AB, et al
Nonresponse data in sexual well-being among breast reconstruction patients-who
are we overlooking?
J Surg Oncol. 2024;129:1192-1201.
- AMBIKA M, Lara S, Faulkner HR, Toncred S, et al
Oncoplastic reconstruction with breast-conserving treatment versus
breast-conserving treatment alone in the elderly.
J Surg Oncol. 2024;129:1187-1191.
N Engl J Med
- VIDULA N, Rodriguez K, Wong AK, Boyraz B, et al
Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer.
N Engl J Med. 2024;390:2011-2022.
NPJ Breast Cancer
- MAI N, Myers S, Shen S, Downs-Canner S, et al
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for
triple negative breast cancer.
NPJ Breast Cancer. 2024;10:39.
- ROSSETTI S, Broege A, Sen A, Khan S, et al
Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR
inhibitors in breast cancer models.
NPJ Breast Cancer. 2024;10:40.
- RUGO HS, Tolaney SM, Loirat D, Punie K, et al
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab
govitecan in metastatic triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:41.
Oncol Rep
- ANWAR S, Zafar M, Hussain MA, Iqbal N, et al
Unravelling the therapeutic potential of forkhead box proteins in breast cancer:
An update (Review).
Oncol Rep. 2024;52:92.
- YANG X, Liang B, Zhang L, Zhang M, et al
Ursolic acid inhibits the proliferation of triple?negative breast cancer
stem?like cells through NRF2?mediated ferroptosis.
Oncol Rep. 2024;52:94.
Oncology
- JEON C, Kang SH, Kim SB, Paik NS, et al
Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a
Post-Marketing Surveillance Study.
Oncology. 2024;102:465-475.
PLoS Comput Biol
- XIE X, Sinha S
Quantitative estimates of the regulatory influence of long non-coding RNAs on
global gene expression variation using TCGA breast cancer transcriptomic data.
PLoS Comput Biol. 2024;20:e1012103.
PLoS Genet
- GOMEZ ACUNA LI, Flyamer I, Boyle S, Friman ET, et al
Transcription decouples estrogen-dependent changes in enhancer-promoter contact
frequencies and spatial proximity.
PLoS Genet. 2024;20:e1011277.
PLoS One
- KALSOOM A, Altaf A, Sattar H, Maqbool T, et al
Gene expression and anticancer evaluation of Kigelia africana (Lam.) Benth.
Extracts using MDA-MB-231 and MCF-7 cell lines.
PLoS One. 2024;19:e0303134.
- CONZ L, Jales RM, Doria MT, Melloni I, et al
Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy
response of breast cancer: Prospective comparison with magnetic resonance and
mammography.
PLoS One. 2024;19:e0302527.
Radiol Imaging Cancer
- HUNT KN, Conners AL, Gray L, Hruska CB, et al
Molecular Breast Imaging Biopsy with a Dual-Detector System.
Radiol Imaging Cancer. 2024;6:e230186.
Radiology
- LAURITZEN AD, Lillholm M, Lynge E, Nielsen M, et al
Early Indicators of the Impact of Using AI in Mammography Screening for Breast
Cancer.
Radiology. 2024;311:e232479.
- LEE AY, Friedewald SM
Clinical Implementation of AI in Screening Mammography: The Essential Role of
Prospective Evaluation.
Radiology. 2024;311:e241124.
Radiother Oncol
- HOGSBJERG KW, Offersen BV
Author's response to Letter-to-the-Editor from Chang JS. concerning: "Benefit of
respiratory gating in the Danish Breast Cancer Group partial breast irradiation
trial".
Radiother Oncol. 2024;197:110351.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016